GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » ROE % Adjusted to Book Value

Smruthi Organics (BOM:540686) ROE % Adjusted to Book Value : 3.64% (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics ROE % Adjusted to Book Value?

Smruthi Organics's ROE % for the quarter that ended in Mar. 2024 was 8.73%. Smruthi Organics's PB Ratio for the quarter that ended in Mar. 2024 was 2.40. Smruthi Organics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 3.64%.


Smruthi Organics ROE % Adjusted to Book Value Historical Data

The historical data trend for Smruthi Organics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics ROE % Adjusted to Book Value Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.97 7.89 4.26 2.83 2.17

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 - 3.87 - 3.64

Competitive Comparison of Smruthi Organics's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's ROE % Adjusted to Book Value falls into.



Smruthi Organics ROE % Adjusted to Book Value Calculation

Smruthi Organics's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.21% / 2.40
=2.17%

Smruthi Organics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.73% / 2.40
=3.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Smruthi Organics (BOM:540686) Business Description

Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines